In today’s complex healthcare landscape, ensuring patients have timely access to critical treatments and therapies is of paramount importance. Managed Access Programs (MAPs) serve as a vital bridge, facilitating access to life-changing medications during various stages of the pharmaceutical journey. At Akesa, we are committed to developing and executing robust MAPs that support patients, healthcare providers, and pharmaceutical companies throughout the access continuum.
Our Comprehensive Managed Access Program Services
Program Development and Integration
Navigating the landscape of access programs can be challenging. That’s why we specialise in program development and seamless integration with your existing processes. We work closely with pharmaceutical companies to create customised MAPs tailored to specific therapies, ensuring they align seamlessly with your overall objectives and operational workflows.
Post Clinical Trial Access
After the conclusion of clinical trials, swift and efficient access to treatments becomes crucial. Our Post Clinical Trial Access programs are designed to bridge the gap between trial completion and product approval, providing eligible patients with the therapies they need while regulatory processes are ongoing.
Pre-registration & Pre-reimbursement Access
Access to treatments shouldn’t be limited by regulatory approval or reimbursement. Our Pre-registration & Pre-reimbursement Access programs enable eligible patients to receive vital medications before formal market authorisation, ensuring that patients in need don’t have to wait for potentially life-saving therapies.
Product Familiarisation Programs
Introducing a new treatment to healthcare providers and patients requires a strategic approach. Our Product Familiarisation Programs are designed to educate and familiarise healthcare professionals and patients with new therapies, ensuring their effective and safe utilisation once they become available.
Expanded Access Programs
Expanded Access Programs (EAPs) provide a lifeline to patients who have exhausted all other treatment options. We develop and manage EAPs that provide access to investigational or unapproved treatments for patients with serious or life-threatening conditions, offering hope and potential life-changing solutions.
To ensure the seamless delivery of therapies, we provide pharmacy services through a central PBS (Pharmacy Benefit Solutions) licensed pharmacy with national coverage. Our pharmacy services guarantee the timely and efficient distribution of medications to patients, regardless of their location.
Why choose Akesa for your Managed Access Program?
Expertise: With years of experience in the healthcare industry, we possess the knowledge and insights needed to design and implement successful MAPs.
Custom Solutions: We understand that every therapy is unique. Our tailored programs ensure that each treatment receives the attention and strategy it deserves.
Patient-Centric Approach: Patient-Centric Approach: Patients are at the heart of what we do. Our programs prioritise their needs, ensuring they receive the care and support they require.
Regulatory Compliance: We stay up-to-date with evolving regulations and compliance requirements, ensuring that your MAPs are always in line with the latest standards.
Global Reach: Our programs can be deployed internationally, making us a valuable partner for pharmaceutical companies seeking to expand their reach.
Let Discovery Live with Akesa
Partner with Akesa for building and managing Managed Access Programs that enhance patient access, support healthcare providers, and drive the success of your pharmaceutical products. Contact us today to learn more about how we can collaborate to ensure access to essential therapies for those who need them most. Together, we can make a difference in healthcare access.